Sign Up to like & get
recommendations!
2
Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.330
Abstract: Belimumab was approved in the United Kingdom (UK) in 2016 as add-on therapy for patients with auto-antibody positive systemic lupus erythematosus (SLE) and high disease activity refractory to standard treatment. Data regarding the effectiveness of…
read more here.
Keywords:
belimumab;
selena sledai;
systemic lupus;
lupus erythematosus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Lupus"
DOI: 10.1177/0961203319886065
Abstract: Objectives To quantify changes in generic patient-reported outcomes against clinically meaningful, disease activity measures in systemic lupus erythematosus (SLE). Methods Using BLISS-52 trial data (867 SLE patients), we estimated the mean difference in change of…
read more here.
Keywords:
index;
disease;
selena sledai;
disease activity ... See more keywords